-
261
The Role of MEF2 Transcription Factor Family in Neuronal Survival and Degeneration
Published 2023-02-01Get full text
Article -
262
-
263
Evaluation of the ATN model in a longitudinal memory clinic sample with different underlying disorders
Published 2021-01-01Get full text
Article -
264
Dephosphorylation Passivates the Seeding Activity of Oligomeric Tau Derived From Alzheimer’s Brain
Published 2021-05-01Get full text
Article -
265
Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations
Published 2017-10-01Get full text
Article -
266
Diagnostic value of serum versus plasma phospho-tau for Alzheimer’s disease
Published 2022-05-01Get full text
Article -
267
-
268
-
269
-
270
THE AYAHUASCA’S PSYCHEDELIC COMPONENT DMT POTENTIATES NEURITOGENESIS IN PC12 CELLS
Published 2023-10-01Get full text
Article -
271
Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease
Published 2024-02-01Get full text
Article -
272
-
273
-
274
Nicotinic Acetylcholine Receptors in Glial Cells as Molecular Target for Parkinson’s Disease
Published 2024-03-01Get full text
Article -
275
Nonlinear Decoding and Asymmetric Representation of Neuronal Input Information by CaMKIIα and Calcineurin
Published 2013-04-01Get full text
Article -
276
-
277
-
278
Clinical stage and plasma neurofilament concentration in adults with Friedreich ataxia
Published 2024-01-01“…Three out of the five FRDA patients displayed a small or moderate increase in the p-NfL value, compared to the age-adjusted cut-offs for p-NfL established in the Clinical Neurochemistry Laboratory at our hospital. The two others were the oldest and most severely affected, displayed normal values according the cut-off values. …”
Get full text
Article -
279
Biomarker-Based Signature of Alzheimer’s Disease in Pre-MCI Individuals
Published 2019-08-01Get full text
Article -
280